BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 23, 2026
Home » Topics » Financings, Medical technology

Financings, Medical technology
Financings, Medical technology RSS Feed RSS

Tetratherix Tetramatrix

Tetratherix lists on ASX in $25M IPO

June 30, 2025
By Tamra Sami
Tetratherix Ltd. raised AU$45 million (US$25 million) in its IPO on the Australian Securities Exchange (ASX:TTX) to support clinical development of its Tetramatrix polymer biomaterial platform to support bone regeneration, tissue spacing and tissue healing.
Read More

Financings for June 30, 2025

June 30, 2025
Med-tech firms raising money in public or private financings, including: Bone Biologics, Escala, Tempus AI.
Read More
Close up of eye and vision test

Forsight Robotics secures $125M for eye surgery robotics platform

June 27, 2025
By Shani Alexander
Forsight Robotics Ltd. secured $125 million in series B financing for its Oryom platform, a robotic system for cataract surgery.
Read More

Financings for June 27, 2025

June 27, 2025
Med-tech firms raising money in public or private financings, including: Aikon Health, Bone Biologics, Carlsmed, Ontrak.
Read More

Financings for June 26, 2025

June 26, 2025
Med-tech firms raising money in public or private financings, including: Calmwave, Hapbee Technologies, Icon Group, Siemens Healthineers, Varian Medical Systems.
Read More
Polyactiva implant

Polyactiva raises $25M series C to advance U.S. clinical programs

June 25, 2025
By Tamra Sami
Ophthalmology company Polyactiva Pty Ltd closed a AU$40 million (US$25 million) series C round to advance late-stage clinical trials in the U.S. of its lead candidate, PA-5108.
Read More

Financings for June 25, 2025

June 25, 2025
Med-tech firms raising money in public or private financings, including: Elfie, Empo Health, Icecure Medical, Lifeward, Nephrolytics, Trisalus Life Sciences.
Read More

Financings for June 24, 2025

June 24, 2025
Med-tech firms raising money in public or private financings, including: Forsight, Jaan, Pavmed, Veris.
Read More

Financings for June 23, 2025

June 23, 2025
Med-tech firms raising money in public or private financings, including: Archimedes Vascular.
Read More
Deski Heart Focus

Deski raises $6M for Heartfocus cardiac imaging software

June 20, 2025
By Shani Alexander
Deski SAS raised $6 million in a seed round to support the launch of its cardiac imaging software, Heartfocus, in the U.S. The AI-driven heart exam tool helps health care professionals perform echocardiograms from any ultrasound probe to enable the early detection of heart disease.
Read More
Previous 1 2 … 18 19 20 21 22 23 24 25 26 … 254 255 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing